Council Members in this Study Group: 283
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Owner and Clinical Director
Coastal Vision ![]()
Hal Breedlove, OD, is the Owner and Clinical Director of Coastal Vision, a five Optometrist practice in Virginia Beach, Chesapeake, and Norfolk Virginia. In practice for over 26 years, he has expertise in a many areas of vision research, patient care, practice management, and optical (contact lenses,...
Steve Rubinstein, ODOptometrist
Sound Shore Vision Care ![]()
Steve Rubinstein, OD, is a Clinical Optometrist at Diamond District Eye Associates and Sound Shore Vision Center, office based practices in New York. Dr. Rubinstein has a biochemical background. He has won the Frank R. Blood award by the Society of Toxicology for the best paper in this peer reviewed...
Gary BarkerPartner/Owner
EYE ASSOCIATES OF WINTER PARK ![]()
Gary Barker, OD, FAAO, is a Partner and Co-Founder of the group practice Eye Associates of Winter Park, Florida. Dr. Barker is the Past-President of the Florida Optometric Association, where he remains active in legislative affairs. Clinically, he has participated in numerous Phase III FDA studiesof...
Optometrist
Hertzog Eye Associates ![]()
Darcy Ryan, OD, is an Optometrist at Hertzog Eye Associates, an Ophthalmological practice in Long Beach, California. He performs routine and specialty adult and pediatric eye exams. He treats and co-manages patients with almost every type of eye condition, including those with glaucoma, microbial infections,...
Karen Yeung, OD, FAAODirector of Optometry
UNIVERSITY OF CALIFORNIA, LOS ANGELES (UCL. ![]()
Karen Yeung, OD, FAAO (Dip CL), is a Director of Optometry at University of California, Los Angeles. Dr. Yeung is a Diplomate in Cornea and Contact Lenses through the American Academy of Optometry with expertise in contact lenses and keratoconus. She is highly involved in clinical research and lecturing,...
Jack Melton, OD, FAAOPresident
Omni Eye Center - Laser Vision ![]()
Jack Melton, OD, FAAO, is the President of Omni Eye Center - Laser Vision in Oklahoma City, OK. He is recognized nationally for his expertise in the field of contact lenses and laser vision corrections. Dr. Melton has served as a professional consultant for a number of contact lens and laser vision...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Contact Lens Nirvana: Hyperpermeable One Day
October 2, 2009
Steve Rubinstein, OD, Optometrist, Sound Shore Vision Care
Hobby assists Irish strategy | www.opticianonline.net
This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.
Competitive Dynamics in Contact Lenses
July 29, 2009
Soft Contact Lens Market by Competitor in The USA | www.researchandmarkets.com
In the United States based on reported sales analysis by Independent Market Research Data; Johnson & Johnson continues to have the lions share of the market with 44% followed by Ciba Vision 22%, Cooper Vision 16% and Bausch & Lomb at 14%
Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
July 23, 2009
Steve Rubinstein, OD, Optometrist, Sound Shore Vision Care
Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com
This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.
Welcome addition to our armament, but overuse potential?
July 14, 2009
Gary Barker, Partner/Owner, EYE ASSOCIATES OF WINTER PARK
Bausch and Lomb (BOL) Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') | www.lifescience-online.com
Potential for overuse and more drug-resistant bacteria
A drop in the price of OTC allergy eye drops?
July 5, 2009
Steve Rubinstein, OD, Optometrist, Sound Shore Vision Care
Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’ | Top News | www.topnews.in
By adding a third OTC antihistamine eye drop to the mix the price competition should make the cost to the consumer decrease.